|
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II |
22/04/2016 |
CIM |
|
Curmeric- Safety-Community-Quarantine-COVID-19 |
22/01/2021 |
CEADEN |
|
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19 |
22/01/2021 |
CEADEN |
|
Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19 |
22/01/2021 |
CEADEN |
|
Post EUA study of Itolizumab in COVID-19 |
21/03/2022 |
CIM |
|
SURFACEN ARDS. Pediatrics. Phase III |
2013-06-21 |
CENSA |
|
CONTROLLED, DOUBLE-BLIND, RANDOMIZED, MULTICENTER, FASE IIIb TRIAL DESIGNED TO EVALUATE THE EFFICACY AND TOLERABILITY OF THE FIXED COMBINATION OF THIOCOLCHICOSIDE PLUS DICLOFENAC POTASSIUM IN ACUTE PAINFUL MUSCLE CONTRACTURE |
2013-06-20 |
GUTIS |
|
EGF-based vaccine with VChTV Schedule in hormone-refractory prostate tumors |
2013-06-19 |
CIM |
|
Study of the tetanus vaccine vax-TET®-5 |
2013-06-10 |
FINLAY |
|
NeuroEPO in healthy volunteers. |
2013-06-10 |
CIMAB |
|
Transthoracoscopic Sympathectomy T-3 and T-4 in moderate palmar Hyperhidrosis . |
2013-05-24 |
CNCMA |
|
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study) |
2013-05-16 |
CIGB |
|
Zolpidem to treat disorders of consciousness |
2013-03-21 |
INN |
|
Inmunogenicity-PCV-Carriage-Venezuelan High Risk Children |
2013-03-06 |
SAIB |
|
ior EPOCIM ® in the management of anemia of the preterm infant.Phase IV. |
2013-02-26 |
CIMAB |
|
Squamous cell carcinoma interferons (CECIN study) |
2013-02-01 |
CIGB |
|
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) |
2013-01-18 |
CIGB |
|
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study) |
2013-01-18 |
CIGB |
|
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I |
2013-01-04 |
BIOCEN |
|
T1h in severe psoriasis-expanded access program (PUCE) |
2012-07-20 |
CIM |
